AngioDynamics, Inc.
ANGO · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.13 | -0.48 | 0.37 | 0.41 |
| FCF Yield | -3.94% | 4.31% | -3.94% | 0.59% |
| EV / EBITDA | -204.30 | 164.61 | -1,032.72 | 130.76 |
| Quality | ||||
| ROIC | -5.43% | -2.81% | -4.69% | -5.28% |
| Gross Margin | 55.29% | 52.67% | 53.97% | 54.78% |
| Cash Conversion Ratio | 1.46 | -3.11 | 2.99 | -0.23 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.62% | -4.78% | -5.40% | -4.40% |
| Free Cash Flow Growth | -192.30% | 220.57% | -992.42% | 108.66% |
| Safety | ||||
| Net Debt / EBITDA | 20.64 | -25.41 | 120.85 | -27.40 |
| Interest Coverage | -2,664.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.54 | 0.61 | 0.53 | 0.50 |
| Cash Conversion Cycle | 131.44 | 116.55 | 150.37 | 138.49 |